Lercanidipine

GPTKB entity

Statements (39)
Predicate Object
gptkbp:instanceOf gptkb:drug
beta blocker
gptkbp:approvalYear 1997
gptkbp:ATCCode C08CA13
gptkbp:bioavailability 10%
gptkbp:CASNumber 100427-26-7
gptkbp:category antihypertensive agent
gptkbp:chemicalClass dihydropyridine
gptkbp:contraindication pregnancy
severe liver impairment
gptkbp:discoveredBy gptkb:Recordati
gptkbp:eliminationHalfLife 8-10 hours
gptkbp:excretion urine
gptkbp:hasMolecularFormula C36H41ClN2O6
https://www.w3.org/2000/01/rdf-schema#label Lercanidipine
gptkbp:IUPACName 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
gptkbp:KEGGID D08144
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction blocks L-type calcium channels
gptkbp:meltingPoint 198-199°C
gptkbp:metabolism liver
gptkbp:pregnancyCategory gptkb:C_(Australia)
gptkbp:proteinBinding >98%
gptkbp:PubChem_CID gptkb:CHEMBL1423
DB00555
59377
65978
gptkbp:routeOfAdministration oral
gptkbp:sideEffect edema
headache
palpitations
flushing
gptkbp:synonym gptkb:Zanidip
gptkb:Lercadip
gptkbp:UNII 8JZ2786R6F
gptkbp:usedFor hypertension
gptkbp:bfsParent gptkb:Recordati
gptkb:Servier_Pharmaceuticals
gptkbp:bfsLayer 7